HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 6 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $522,208 | -3.2% | 14,129 | 0.0% | 0.01% | -6.7% |
| Q3 2023 | $539,728 | +23.1% | 14,129 | +16.2% | 0.02% | +36.4% |
| Q2 2023 | $438,431 | -8.6% | 12,155 | -3.2% | 0.01% | -15.4% |
| Q1 2023 | $479,552 | +341.7% | 12,557 | +558.1% | 0.01% | +333.3% |
| Q4 2022 | $108,565 | +35.7% | 1,908 | -5.6% | 0.00% | 0.0% |
| Q3 2022 | $80,000 | -81.3% | 2,022 | -79.2% | 0.00% | -75.0% |
| Q2 2022 | $428,000 | – | 9,736 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 7,048,282 | $126,799,000 | 27.23% |
| First Light Asset Management, LLC | 1,630,591 | $29,334,000 | 5.01% |
| SNYDER CAPITAL MANAGEMENT L P | 3,393,057 | $61,041,000 | 3.48% |
| Bellevue Group AG | 7,663,956 | $137,874,000 | 2.67% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 307,633 | $5,531,000 | 2.52% |
| Lombard Odier Asset Management (Switzerland) SA | 900,000 | $16,191,000 | 2.17% |
| Elk Creek Partners, LLC | 654,362 | $11,772,000 | 2.02% |
| DOHENY ASSET MANAGEMENT /CA | 127,110 | $2,254,000 | 1.79% |
| Granite Investment Partners, LLC | 1,277,438 | $22,981,000 | 1.49% |
| Amia Capital LLP | 69,409 | $1,249,000 | 1.11% |